← Back

The T1D Fund

vc$250MCo-invests

◆ Fund Size

$250M

◆ Check Size

$1.0M→$10.0M

◆ Location

United States

◆ Portfolio

25 companies

◆ Activity

Statusactively investing

◆ Links

◆ Share this fund

◆ Investment Thesis

Focus on accelerating life-changing solutions to treat, prevent, and ultimately cure type 1 diabetes through equity investments in companies pursuing disease-modifying or curative potential.

◆ About The T1D Fund

The T1D Fund is an impact investment fund and venture philanthropy affiliate of Breakthrough T1D, focused exclusively on accelerating treatments, preventions, and cures for type 1 diabetes (T1D) through equity investments in early-stage biotech companies. It co-invests with venture capital, biopharma, and foundations in a modality-agnostic approach across autoimmune therapies, cell replacement, regeneration, and metabolic control. All returns are recycled into new T1D investments to maximize philanthropic impact.

◆ Sectors

BiotechDrug DiscoveryMedtechDigital Health

◆ Stages

seed

◆ Geography Focus

global

◆ Team

NameTitleRoleLinks
Aaron J. Kowalski, Ph.D.—Senior
Brady Bohrmann—Senior
Dan McNamara—Senior
Eric Shen—Senior
Frank Martin, Ph.D.—Senior
Grant Beard—Senior
Jason Snipe—Senior
Joe Lacher—Senior
John Cammett—Senior
Karen Jordan—Senior
Lucio Iannone, Ph.D.—Senior
Mike Boyle—Senior
Peter Gottlieb, M.D.—Senior
Sylvia Tobé, Ph.D.PartnerSenior
Teresa Foy, Ph.D.—Senior
Daniel Flicker, Ph.D.—Mid
Katie ElliasPartner—
Matt Williams—Mid
Morgan Janes, Ph.D.—Junior
Peyman Hosseinchi—Mid
Steven St. PeterPartner—
Valerie Su, Ph.D.—Junior
Yash Malliwal—Junior

◆ Notable Investments

25+ portfolio companies (details on t1dfund.org/our-portfolio/)Zag BioZucara TherapeuticsIslex TherapeuticsDiogenXVanqua BioRectify PharmaBiolinqCour PharmaceuticalsVTV TherapeuticsSeraxisSana BiotechnologyKriya TherapeuticsZucara Therapeutics Inc.Aspect BiosystemsCour PharmaMatchpoint TherapeuticsCaspian TherapeuticsCOUR PharmaBigfoot Biomedical

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does T1D Fund invest in?

T1D Fund invests in Biotech, Drug Discovery, Medtech and Digital Health at the seed stage.

Which geographies does T1D Fund focus on?

T1D Fund focuses on global, and is headquartered in United States.

What is T1D Fund's typical check size?

T1D Fund typically writes checks of $1M to $10M.